Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.59 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL273324 | 1.00 | LMNA (0.59) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL273323 | 1.00 | LMNA (0.59) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| Ciclactate SCHEMBL2111243 | 0.88 | LMNA (0.62) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL26822918 | 0.85 | LMNA (0.42) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL17639951 | 0.84 | LMNA (0.54) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL19185119 | 0.82 | LMNA (0.56) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL9594198 | 0.82 | LMNA (0.59) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL11591288 | 0.82 | ALDH1A1 (0.56) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL11591282 | 0.82 | ALDH1A1 (0.56) | LMNANR1I2ABCB11ALDH1A1CYP3A4 | |
| SCHEMBL10883498 | 0.82 | LMNA (0.52) | LMNANR1I2ABCB11ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133856-B2 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2012-03-13 | — | — | US | claimed |
| EP-1648526-B1 | CIS-3,3,5-TRIMETHYLCYCLOHEXYL ESTERS | SYMRISE GMBH & CO KG (DE) | 2009-09-09 | — | — | EP | claimed |
| US-20060211597-A1 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2006-09-21 | — | — | US | claimed |
| CN-113167695-A | Device for collecting volatile organic compounds | 法国由内政部代表 | 2021-07-23 | — | — | CN | disclosed |
| WO-2017071793-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2017-05-04 | — | — | WO | disclosed |
| US-8133856-B2 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2012-03-13 | — | — | US | disclosed |
| US-7157411-B2 | Odor neutralizers | SYMRISE GMBH & CO. KG (DE) | 2007-01-02 | — | — | US | disclosed |
| US-20060211597-A1 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1239890-B1 | ODOR NEUTRALIZERS | SYMRISE GMBH & CO KG (DE) | 2004-11-10 | — | — | EP | disclosed |
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | disclosed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
| US-5310757-A | Hypolipemic, hypocholesterol | PANMEDICA (FR) | 1994-05-10 | — | — | US | disclosed |
| US-5310757-A | Hypolipemic, hypocholesterol | PANMEDICA (FR) | 1994-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068295-A1 | Odor neutralizers | OXER1, OR51E2, OR10J3 | LMNA 3855/4885NR1I2 425/4885ABCB11 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.